Premium
Insulin degludec (Tresiba): new ultra long‐acting basal insulin
Author(s) -
Chaplin Steve,
Joseph Frank
Publication year - 2013
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1092
Subject(s) - insulin degludec , medicine , basal insulin , insulin , diabetes mellitus , basal (medicine) , type 2 diabetes , intensive care medicine , endocrinology
Insulin degludec is a new long‐acting insulin for use in type 1 and 2 diabetes. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events, and Dr Frank Joseph discusses its place in diabetes treatment compared with other longacting insulins.